J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

Data Compilation
#PharmaFlow

Pipeline Prospector June 2025: Sanofi, AbbVie, Eli Lilly, BioNTech lead pharma M&A spree; BMS, Astra ink major collaborations

Stock Recap
#PipelineProspector

FS-3218

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 18 USDMF, 4 EU WC, 6 NDC API, 13 Listed Suppliers, $ API Reference Price

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

13 FDF Dossiers, 12 FDA Orange Book, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Rochem International Inc, 8 SPI Pharma, 8 DKSH, 5 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 ACG Worldwide, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 19 BASF, 11 Corel Pharma Chem, 5 DFE Pharma, 7 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 3 Ingredion Pharma Solutions, 29 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 19 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

74 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 28 Direct Compression, 26 Thickeners and Stabilizers, 26 Controlled & Modified Release, 25 Lubricants & Glidants, 24 Granulation, 20 Disintegrants & Superdisintegrants, 16 Co-Processed Excipients, 14 Film Formers & Plasticizers, 13 Solubilizers, 11 Taste Masking, 10 Rheology Modifiers, 9 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 6 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 3 Parenteral, 2 Topical, 2 Coloring Agents, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions

11 US Medicaid Prescriptions

MARKET PLACE

4 APIs

4 APIs

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
28/06/2025	Chunghwa Chemical Synthesis & Biotech	Taiwan	Chunghwa Chemical Synthesis & Biotech. Ltd	52076-6231	METAXALONE	2018-01-11	2025-12-31	BULK INGREDIENT	POWDER (50kg/50kg)
28/06/2025	Angelini Pharma	Italy	Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. Spa	50056-1999	Metaxalone	2000-10-19	2025-12-31	BULK INGREDIENT	POWDER (1kg/kg)

FS-3218

FS-3218

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers

18 USDMF

4 EU WC

6 NDC API

13 Listed Suppliers

$ API Reference Price

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

13 FDF Dossiers

12 FDA Orange Book

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

2 Rochem International Inc

8 SPI Pharma

8 DKSH

5 Faran Shimi Pharmaceutical

6 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 ACG Worldwide

1 Aeon Procare

1 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

19 BASF

11 Corel Pharma Chem

5 DFE Pharma

7 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

5 Ideal Cures

3 Ingredion Pharma Solutions

29 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

17 Microlex e.U

3 Nitika Pharmaceutical Specialities

3 Novo Excipients

4 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

19 Roquette

7 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

3 The Dow Chemical Company

1 Ulanqab Kema New Material

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

74 Fillers, Diluents & Binders

49 Coating Systems & Additives

28 Direct Compression

26 Thickeners and Stabilizers

26 Controlled & Modified Release

25 Lubricants & Glidants

24 Granulation

20 Disintegrants & Superdisintegrants

16 Co-Processed Excipients

14 Film Formers & Plasticizers

13 Solubilizers

11 Taste Masking

10 Rheology Modifiers

9 Chewable & Orodispersible Aids

TABLET;ORAL - 400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons